Accelerated Development of COVID-19 Vaccines: Technology Platforms, Benefits, and Associated Risks.

Wagner, Ralf; Hildt, Eberhard; Grabski, Elena; Sun, Yuansheng; Meyer, Heidi; Lommel, Annette; Keller-Stanislawski, Brigitte; Müller-Berghaus, Jan; Cichutek, Klaus.

Afiliação

Wagner R; Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, 63225 Langen, Germany.
Hildt E; Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, 63225 Langen, Germany.
Grabski E; Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, 63225 Langen, Germany.
Sun Y; Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, 63225 Langen, Germany.
Meyer H; Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, 63225 Langen, Germany.
Lommel A; Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, 63225 Langen, Germany.
Keller-Stanislawski B; Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, 63225 Langen, Germany.
Müller-Berghaus J; Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, 63225 Langen, Germany.
Cichutek K; Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, 63225 Langen, Germany.